Profit and Loss: America on Dialysis
Kidney disease affects millions of Americans, but corporate capture of dialysis, along with disparities in treatment and transplant access, mean that not everyone’s journey is the same
Kidney Dialysis Is a Booming Business—Is It Also a Rigged One?
A new California law aims to curb what sponsors say is profiteering by dialysis centers. But are there any easy answers?
For Black and Brown Kidney Patients, There Are Higher Hurdles to Care
Minority patients are diagnosed later, stay on dialysis longer and are added to transplant lists less quickly. Why?
Should Your Kidney Doctor Have a Financial Stake in Dialysis?
Joint ventures between nephrologists and dialysis centers have expanded treatment. Critics ask: At what cost?
The Lifesaving Potential of Less Than Perfect Donor Kidneys
Demand for healthy kidneys has long outstripped supply. But better testing and treatment are expanding the donor pool
Few Kidney Patients Can Access Palliative Care or Hospice—Why?
Treatments that reduce suffering and incorporate patient values aren’t common in kidney disease care. That’s changing
America on Dialysis
Kidney disease affects millions of Americans, but corporate capture of dialysis, along with disparities in treatment and transplant access, mean that not everyone's journey is the same...
